PeptidePub Blog

Research findings, pricing news, and vendor analysis across the peptide market.

Showing 1 to 30 of 163

Peptide Comparisons10 min read

CagriSema vs Tirzepatide 5 Mg: What REIMAGINE 5 Actually Compared

REIMAGINE 5 directly compared CagriSema 1.0 mg/1.0 mg with tirzepatide 5 mg in adults with type 2 diabetes. Here is what the 12.4% versus 9.1% result means, what it does not prove, and how current cagrilintide, semaglutide, and tirzepatide prices and COA evidence compare.

Read more →
Buyer Guides10 min read

Is KT Peptides Legit? Prices, COA Gaps, and Buyer Checks

KT Peptides has a live 79-product catalog and unusually low 10-vial pack pricing, but its public proof needs careful review. Here is what the posted COAs show, what they leave unverified, and how buyers can compare price per verified milligram before ordering.

Read more →
Buyer Guides10 min read

CJC-1295 DAC vs No DAC: Half-Life, Price Per Mg, and Buyer Checks

CJC-1295 with DAC and CJC-1295 without DAC share a core peptide but differ sharply in duration, labeling, research evidence, and cost math. This guide shows buyers how to verify the exact variant, compare current price per mg, and avoid paying for an ambiguously labeled vial.

Read more →

STOP PIECING IT TOGETHER

One article at a time is a slow way to learn peptides.

We wrote the shortcut: five books, 45 compounds, every claim graded by the strength of the real evidence. No hype, no gatekeeping, and free updates for life whenever the market shifts. Most readers say it replaces months of forum digging.

Get the Handbook30-day money-back guarantee. Free updates for life.